VNI: N-[(1R)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl]-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide
VNI is a Ligand Of Interest in 3GW9 designated by the RCSB
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3GW9_VNI_C_490 | 81% | 14% | 0.07 | 0.968 | 1.7 | 2.13 | 9 | 17 | 0 | 0 | 100% | 1 |
| 3GW9_VNI_D_490 | 73% | 17% | 0.081 | 0.95 | 1.56 | 1.94 | 6 | 10 | 1 | 0 | 100% | 1 |
| 3GW9_VNI_B_490 | 68% | 15% | 0.093 | 0.95 | 1.65 | 2.02 | 5 | 9 | 2 | 0 | 100% | 1 |
| 3GW9_VNI_A_490 | 66% | 16% | 0.097 | 0.946 | 1.66 | 1.98 | 6 | 11 | 1 | 0 | 100% | 1 |
| 4UYL_VNI_A_590 | 66% | 16% | 0.095 | 0.943 | 1.7 | 1.88 | 9 | 16 | 2 | 0 | 100% | 1 |
